Latest news

A Patient Charter, aimed at ensuring consistent support and care for anyone diagnosed with the disease, has been created by Pancreatic Cancer UK.

Alex Ford, Chief Executive of Pancreatic Cancer UK comments on the decision to retain routine NHS access to Abraxane for eligible patients in Wales.

New research offers an insight into how our immune system might be able to recognise unique markings within a tumour, allowing the body to fight cancer.

Pancreatic Cancer UK is today revealing its new brand identity, which will help the charity transform the future for patients and families over the next five years.

Researchers have reclassified pancreatic cancer as four distinct types, a discovery that could offer new opportunities to treat the disease, according to their study published in Nature.